A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole (Q34174536)

31 July 2017

1 reference

title

A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole (English)

1 reference

31 July 2017

1 reference

1

Lars Olbe

1 reference

31 July 2017

2

Enar Carlsson

1 reference

31 July 2017

Per Lindberg

3

1 reference

31 July 2017

publication date

1 February 2003

1 reference

Nature Reviews Drug Discovery

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

132-139

1 reference

Omeprazole: the first proton pump inhibitor

31 July 2017

cites work

1 reference

A Micro-Method for the Study of Acid Secretory Function in Isolated Human Oxyntic Glands from Gastroscopic Biopsies

31 March 2020

1 reference

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase

31 March 2020

1 reference

Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole

31 March 2020

1 reference

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

31 March 2020

1 reference

Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial

31 March 2020

1 reference

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats

31 March 2020

1 reference

Enterochromaffin-like cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine

31 March 2020

1 reference

Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression

31 March 2020

1 reference

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

31 March 2020

1 reference

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis

31 March 2020

1 reference

24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients

31 March 2020

1 reference

The mechanism of action of the gastric acid secretion inhibitor omeprazole

31 March 2020

1 reference

Membrane topology and omeprazole labeling of the gastric H+,K(+)-adenosinetriphosphatase

31 March 2020

1 reference

Reversal of antisecretory activity of omeprazole by sulfhydryl compounds in isolated rabbit gastric glands

31 March 2020

1 reference

Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.

31 March 2020

1 reference

Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion

31 March 2020

1 reference

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

31 March 2020

1 reference

Sponsored congress attendance--does it happen, does it matter?

31 March 2020

1 reference

The first practical method for asymmetric epoxidation

31 March 2020

1 reference

Resolution of the enantiomers of omeprazole and some of its analogues by liquid chromatography on a trisphenylcarbamoylcellulose-based stationary phase. The effect of the enantiomers of omeprazole on gastric glands

31 March 2020

1 reference

Asymmetric synthesis of esomeprazole

31 March 2020

1 reference

Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole

31 March 2020

1 reference

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa

31 March 2020

1 reference

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease

31 March 2020

1 reference

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

31 March 2020

1 reference

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

31 March 2020

1 reference

Helicobacter pyloriInfection

31 March 2020

1 reference

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

31 March 2020

1 reference

Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease

31 March 2020

1 reference

Potential alternatives to COX 2 inhibitors

31 March 2020

1 reference

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD1010

1 reference

Dimensions Publication ID

31 July 2017

1037219697

0 references

1 reference